A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/4725 (2006.01) A61K 31/277 (2006.01) A61K 31/472 (2006.01) A61K 39/395 (2006.01) A61P 27/02 (2006.01)
Patent
CA 2702984
The present invention provides compounds and methods for the treatment of diabetic retinopathy. In particular, LFA-I antagonists are described herein to be used in the treatment of diabetic retinopathy. One aspect of the invention provides for diagnosis of diabetic retinopathy and administration of a LFA-I antagonist, after the patient is diagnosed with diabetic retinopathy.
Cette invention concerne des composés et des procédés pour le traitement de la rétinopathie diabétique. En particulier, l'invention concerne des antagonistes LFA-I à utiliser dans le traitement de la rétinopathie diabétique. Un aspect de l'invention concerne le diagnostic de la rétinopathie diabétique et l'administration d'un antagoniste LFA-I, après que le patient est diagnostiqué comme porteur d'une rétinopathie diabétique.
Burnier John
Gadek Thomas
Semba Charles
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
Sarcode Corporation
LandOfFree
Compositions and methods for treatment of diabetic retinopathy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions and methods for treatment of diabetic retinopathy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for treatment of diabetic retinopathy will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1819184